Release Date: 25/01/21 12:37 Summary: Response to Shareholder Circular Price Sensitive: No Download Document 167.35KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%